NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Copyright Public domain Remove constraint Copyright: Public domain Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

7. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

10. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

14. Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home

16. Access and use of electronic health information by individuals with cancer: 2017-2018

18. The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

19. Acne vulgaris: establishing effectiveness of drugs intended for treatment

20. Adaptive designs for clinical trials of drugs and biologics

24. Addressing teen pregnancy risks for youth living in out-of-home care: implementing POWER through choices 2010 : implementation report

25. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

26. The Admissibility of Scientific Evidence in Court

27. Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees

28. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

29. Advancement of emerging technology applications for pharmaceutical innovation and modernization

31. Adverse events in long-term-care hospitals: national incidence among Medicare beneficiaries

32. The Affordable Care Act and African Americans

33. The Affordable Care Act and Asian Americans and Pacific Islanders

34. The Affordable Care Act and Latinos

35. The Affordable Care Act and adolescents

36. The Affordable Care Act and women

37. Affordable Care Act has led to historic, widespread increase in health insurance coverage

38. Affordable Care Act: IRS should mitigate limitations of data to be used for the age and gender adjustment for the tax on high-cost health plans : report to Congressional committees

39. The Affordable Care Act: advancing the health of women and children

41. The aging services network: accomplishments and challenges in serving a growing elderly population

42. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

43. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

45. Allergic rhinitis: developing drug products for treatment

48. An American Indian/Alaska Native suicide prevention hotline: literature review and discussion with experts

49. [Amphioxus and ascidian]

50. Amyotrophic lateral sclerosis: developing drugs for treatment

51. An analysis of private-sector prices for hospital admissions

53. Analysis of supply, distribution, demand, and access issues associated with immune globulin intravenous (IGIV): final report

57. Anthrax: developing drugs for prophylaxis of inhalational anthrax

58. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

60. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

61. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

66. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff

72. Arthroscopy pump tubing sets intended for multiple patient use - Premarket Notification (510(k)) submissions: guidance for industry and Food and Drug Administration staff

73. As funding for BPA research increased, NIEHS followed its peer review process while also exercising its discretion

74. Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment

76. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

77. Assessing user fees under the biosimilar user fee amendments of 2017

83. BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment

87. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion

90. Basic safety and essential performance of medical electrical equipment, medical electrical systems, and laboratory medical equipment: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

91. A Bauluk

93. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

95. Beyond fair hearings: how five states help Medicaid managed care beneficiaries resolve disputes with health plans

97. Bibliography

98. Billions in estimated Medicare Advantage payments from chart reviews raise concerns

99. Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns

100. Bioanalytical method validation